Floatz logo

.ALPHA.-TEA

Metastatic Lymphoma

Providence Health & ServicesSmall moleculePhase 1Dormant
CC
47/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
95/ 100

Competitive context

289 Active assets in the Metastatic Lymphoma cohort.

Asset / SponsorPhaseRating
VINBLASTINE
Intensity Therapeutics, Inc.
Phase 4BBB
CHLOROPTIC-P S.O.P. COMPONENT PREDNISOLONE
The Lymphoma Academic Research Organisation
Phase 4BBB
BLEOMYCIN
Shandong Provincial Hospital
Phase 4BB
VINCRISTINE SULFATE
Inhye Ahn
Phase 3BB
ETOPOSIDE
Memorial Sloan Kettering Cancer Center
Phase 4BB

View all 50 →

Same molecule, other indications

.ALPHA.-TEA is also rated in:

carcinomaDormant
CC
Indicative ·
47 / 100
View asset →
sarcomaDormant
CC
Indicative ·
47 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →